This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

Upcoming Global Medical Conferences To Feature IRIDEX Proprietary MicroPulse™ Laser Therapy

Stocks in this article: IRIX





MOUNTAIN VIEW, Calif., Sept. 26, 2013 /PRNewswire/ -- IRIDEX (Nasdaq: IRIX) today announced a number of key international conferences and workshops that will feature its proprietary MicroPulse Laser Therapy for the treatment of diabetes and glaucoma related disorders. 

The upcoming European Society of Retina Specialists (EURETINA) conference in Hamburg, Germany will feature an official Instructional Course on the use of IRIDEX' MicroPulse Therapy for retinal disorders such as those caused by complications of diabetes.  EURETINA is Europe's largest society of retina specialists. 

MicroPulse is a vision-preserving laser treatment that does not produce the retinal tissue damage that is often associated with traditional laser therapies.

"Independent, physician-sponsored inclusion within these influential conferences further validates our MicroPulse Laser Therapy, which we believe is well positioned for the current global trend toward value-based healthcare," said Will Moore, IRIDEX President and CEO. "The durable clinical effect combined with the substantial economic benefits for healthcare systems, support the global market opportunity available for our MicroPulse laser technology."

In addition, to address the comprehensive ophthalmologist opportunity in the emerging global markets for IRIDEX, there will be a company-sponsored satellite training meeting at the upcoming European Society of Cataract and Refractive Surgeons (ESCRS) conference.  ESCRS is Europe's leading organization for cataract and refractive surgeons.

The physician-led training will focus on clinical application of IRIDEX' MicroPulse technology as a single-versatile solution to address the needs of comprehensive ophthalmologists in both glaucoma and retina.

"With more than 1,400 global views of IRIDEX' most recent webinar, we are seeing strong interest from physicians in MicroPulse  Laser Therapy as a durable and economically appealing medical solution for both the glaucoma and retina markets," added Moore.

"Recent data regarding MicroPulse laser's effectiveness for patients suffering with glaucoma should prove to be a catalyst for ophthalmologists looking for a versatile solution for their retina, glaucoma, and comprehensive practices." 

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,827.75 +12.81 0.07%
S&P 500 2,072.83 +5.80 0.28%
NASDAQ 4,787.3170 +29.0650 0.61%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs